• ÆäÀ̽ººÏ °øÀ¯
  • Æ®À§ÅÍ °øÀ¯
  • ¹ÌÅõµ¥ÀÌ °øÀ¯
  • URLº¹»ç
  • ´õº¸±â
  • °ü½ÉÀÇ·áÁø µî·Ï

ÀåÀº¾Æ

  • Áø·á°ú

    Áø´Ü°Ë»çÀÇÇаú

  • Àü¹®Áø·áºÐ¾ß

    ¼öÇ÷ÀÇÇÐ, ¼¼Æ÷ Ä¡·á

  • ´ã´çŬ¸®´Ð

ÀåÀº¾Æ

ÀåÀº¾Æ ±³¼öÀÇ Áø·á½Ã°£Ç¥ Áø·á¿¹¾à

Áø·á°ú/¼¾ÅÍ ¿ù È­ ¼ö ¸ñ ±Ý Åä Àü¹®Áø·á°ú¸ñ
Áø´Ü°Ë»çÀÇÇаú - - - - - - ¼öÇ÷ÀÇÇÐ , ¼¼Æ÷ Ä¡·á

ÀåÀº¾Æ ±³¼öÀÇ »ó¼¼Á¤º¸

ÇзÂ

more
  • 1986 .03  ~  1992 .02  :  Áß¾Ó´ëÇб³ Àǰú´ëÇÐ Çлç
  • 1995 .09  ~  1997 .08  :  Áß¾Ó´ëÇб³ Àǰú´ëÇÐ ´ëÇпø ¼®»ç
  • 1997 .09  ~  2000 .02  :  Áß¾Ó´ëÇб³ Àǰú´ëÇÐ ´ëÇпø ¹Ú»ç

°æ·Â

more
  • 1995 .03  ~  1999 .02  :  Áß¾Ó´ëÇб³ ºÎ¼Óº´¿ø Áø´Ü°Ë»çÀÇÇаú Àü°øÀÇ
  • 1999 .03  ~  1999 .11  :  ¾ÆÁÖ´ëÇб³ ºÎ¼Óº´¿ø Áø´Ü°Ë»çÀÇÇаú ÀüÀÓÀÇ
  • 1999 .12  ~  2001 .01  :  Çѱ¹°Ç°­°ü¸®Çùȸ ºÎ»êÁöºÎ Áø´Ü°Ë»çÀÇÇаú °úÀå
  • 2001 .03  ~  2001 .11  :  °í·Á´ëÇб³ ±¸·Îº´¿ø Áø´Ü°Ë»çÀÇÇаú ÀüÀÓÀÇ
  • 2001 .12  ~  2003 .02  :  ¼­¿ï ¼º¾Öº´¿ø Áø´Ü°Ë»çÀÇÇаú °úÀå
  • 2003 .03  ~  2004 .06  :  °í·Á´ëÇб³ ¾È»êº´¿ø Áø´Ü°Ë»çÀÇÇаú ÀÓ»óÁ¶±³¼ö
  • 2004 .07  ~  2011 .10  :  ¹Ì½Ã°£ ÁÖ¸³´ëÇб³ ¼¼Æ÷ÀçÆí¼º½ÇÇè½Ç ¹Ú»çÈÄ¿¬±¸¿ø
  • 2011 .11  ~  2015 .08  :  ¹Ì½Ã°£ ÁÖ¸³´ëÇб³ ¼¼Æ÷ÀçÆí¼º½ÇÇè½Ç ¿¬±¸Á¶±³¼ö
  • 2015 .09  ~  2016 .05  :  À»Áö´ëÇб³ ³ë¿øÀ»Áöº´¿ø Áø´Ü°Ë»çÀÇÇаú Àü¹®ÀÇ
  • 2016 .06  ~   :  °í·Á´ëÇб³ ¾È»êº´¿ø Áø´Ü°Ë»çÀÇÇаú ÀÓ»ó±³¼ö

ÇÐȸȰµ¿

more
  • 1992 .03  ~   :  ´ëÇÑÀÇ»çÇùȸ Á¤È¸¿ø
  • 1999 .03  ~   :  ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ Á¤È¸¿ø
  • 1999 .03  ~   :  ´ëÇÑÀÓ»ó°Ë»çÁ¤µµ°ü¸®ÇÐȸ Á¤È¸¿ø
  • 2000 .03  ~   :  ´ëÇÑÇ÷¾×ÇÐȸ Á¤È¸¿ø
  • 2002 .03  ~   :  ´ëÇÑÁø´ÜÇ÷¾×ÇÐȸ Á¤È¸¿ø
  • 2003 .03  ~   :  ´ëÇѼöÇ÷ÇÐȸ Á¤È¸¿ø
  • 2005 .06  ~   :  ±¹Á¦Áٱ⼼Æ÷ÇÐȸ(International Society for Stem Cell Research) Á¤È¸¿ø
  • 2015 .11  ~   :  ´ëÇÑÁٱ⼼Æ÷ÇÐȸ Á¤È¸¿ø
  • 2016 .06  ~   :  ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ Á¤È¸¿ø

³í¹®

more
  • [SCI] (An Automated Draft Report Generator for Peripheral Blood Smear Examinations Based on Complete Blood Count Parameters)
  • [SCI] (Human Induced Pluripotent Stem Cells : Clinical Significance and Applications in Neurologic Diseases)
  • [SCI] (Analysis of bone marrow supernatant neutrophil gelatinaseassociated lipocalin and hematological parameters in hematological malignancy)
  • [SCI] (Derivation of Ethnically Diverse Human Induced Pluripotent Stem Cell Lines)
  • [SCI] (Caudalized human iPSC-derived neural progenitor cells produce neurons and glia but fail to restore function in an early chronic spinal cord injury model)
  • [SCI] (Downregulation of H19 improves the differentiation potential of mouse parthenogenetic embryonic stem cells)
  • [SCI] (Generation of leukemia inhibitory factor and basic fibroblast growth factor-dependent induced pluripotent stem cells from canine adult somatic cells)
  • [SCI] (Chemotherapy-induced late transgenerational effects in mice)
  • [SCI] (Mitochondrial rejuvenation after induced pluripotency)
  • [SCI] (The influence of donor nucleus source on the outcome of zebrafish somatic cell nuclear transfer)
  • [SCI] (Human-induced pluripotent stem cells produced under xeno-free conditions)
  • [SCI] (Dynamic epigenetic regulation of the Oct4 and Nanog regulatory regions during neural differentiation in rhesus nuclear transfer embryonic stem cells)
  • [SCI] (Telomere dynamics in human cells reprogrammed to pluripotency)
  • [SCI] (Increased cellular turnover in response to fluoxetine in neuronal precursors derived from human embryonic stem cells)
  • [SCI] (Alteration of platelet counts and lipid profiles after treatment of acute Plasmodium vivax)
  • [SCI] (Seroprevalence to the circumsporozoite protein peptide antigen of Plasmodium vivax in Korean children)
  • [SCI] (Seroprevalence of malaria infections in Korean troops on a peacekeeping mission in East Timor from 2001 to 2002)
  • [SCI] (Prevalence of antibodies to the circumsporozite protein of Plasmodium vivax in five different regions of Korea)
  • [SCI] (Effects of endothelial cells and mononuclear leukocytes on platelet aggregation)

ÃÖÁ¾¼öÁ¤ÀÏ : 2020.11.04